The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

cobaltbiofuels.com

Total Raised

$48M

Investors Count

10

Deal Terms

3

cobalt biofuels Funding, cobalt biofuels Valuation & cobalt biofuels Revenue

4 Fundings

cobalt biofuels's latest funding round was a Series E for on October 30, 2012.

cobalt biofuels's valuation in May 2011 was $59.22M.

cobalt biofuels's latest post-money valuation is from May 2011.

Sign up for a free trial to see cobalt biofuels's valuations in October 2008, November 2006 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

10/30/2012

Series E

0

FY undefined

5/2/2011

Series D

$99M

$59.22M

0

FY undefined

10

10/13/2008

Series C

$99M

$99M

0

FY undefined

10

11/17/2006

Series B

$99M

$99M

0

FY undefined

0

Date

10/30/2012

5/2/2011

10/13/2008

11/17/2006

Round

Series E

Series D

Series C

Series B

Amount

$99M

$99M

$99M

Investors

Valuation

$59.22M

$99M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

10

10

0

cobalt biofuels Deal Terms

3 Deal Terms

cobalt biofuels's deal structure is available for 3 funding rounds, including their Series D from May 02, 2011.

Round

Series D

Series C

Series B

Funding Date

$99M

$99M

$99M

Pre-Money Valuation

$99M

$99M

$99M

Post-Money Valuation

$99M

$99M

$99M

Amount Raised

$99M

$99M

$99M

Shares Authorized

Issuance Price

$99M

$99M

$99M

Dividend Rate

$99M

$99M

$99M

Liquidation Preferences

$99M

$99M

$99M

Liquidation Price

Participation

$99M

$99M

Conversion Price

Anti Dilution

$99M

$99M

$99M

General Voting

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series D

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series C

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

cobalt biofuels Investors

10 Investors

cobalt biofuels has 10 investors. VantagePoint Capital Partners invested in cobalt biofuels's Series D funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/17/2006

10/30/2012

4
Series C, Series B (2006), Series E (2012), Series D (2011)

Venture Capital

California

10/13/2008

10/30/2012

3
Series C, Series E (2012), Series D (2011)

Asset/Investment Management

10/13/2008

10/30/2012

3
Series C, Series E (2012), Series D (2011)

Venture Capital

Netherlands

00/00/0000

00/00/0000

Pinnacle Ventures

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

@Ventures

Subscribe to see more

Venture Capital

Massachusetts

First funding

11/17/2006

10/13/2008

10/13/2008

00/00/0000

00/00/0000

Last Funding

10/30/2012

10/30/2012

10/30/2012

00/00/0000

00/00/0000

Investor

Pinnacle Ventures

@Ventures

Rounds

4
Series C, Series B (2006), Series E (2012), Series D (2011)
3
Series C, Series E (2012), Series D (2011)
3
Series C, Series E (2012), Series D (2011)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Asset/Investment Management

Venture Capital

Venture Capital

Venture Capital

Location

California

Netherlands

California

Massachusetts

You May Also Like

B
BioEnergy International

BioEnergy is a privately-held science and technology company focused on the development and commercialization of next generation biorefineries for the production of high-value bio-based chemicals and fuels from renewable feedstock.

E
Ethos

Ethos was established in 2007 to produce low cost ethanol and related biofuels in the CAFTA, CBI and ATP regions of Central and South America as well as the CaribbeanBasin. Ethos, founded by GreatPoint Ventures and Khosla Ventures, is focused on leveraging partnerships with well-entrenched local groups in relevant agribusinesses to acquire underutilized sugar mills and sugarcane lands and to modernize them for biofuels production. As a project development company, Ethos aims to bring a dominant platform for low cost production of biofuels by combining best of breed partners, an advanced technology portfolio and experienced founders with a track record of building successful alternative energy businesses.

Viridos Logo
Viridos

Viridos is dedicated to developing and commercializing genomic-driven solutions to address global energy and environmental challenges. The company's main research and business programs are focused on the following major bioenergy areas: designing advanced biofuels with superior properties compared to ethanol and biodiesel; harnessing photosynthetic organisms to produce value-added products directly from sunlight and carbon dioxide; developing new biological solutions to increase production and/or recovery rates of subsurface hydrocarbons and developing high-yielding, more disease resistant and economic feedstocks. It was founded in 2005 and is based in La Jolla, California.

C
Chemrec AB

CHEMREC gasification technology - turns pulp and paper mills into biorefineries.nCHEMREC is helping pulp and paper mills transform into Biorefineries with a unique, black liquor gasification technology. Opening up new markets in sustainable, low-carbon chemicals and fuels will be a step-change in the industry.nFull implementation of the Chemrec technology in all Swedish pulp mills would yield about 6 000 000 tons of CO2 reduction per year or roughly 10 % of current Swedish CO2 emissions while supplying 25 % of current Swedish automotive fuel consumption.nThe technology has potential to globally provide motor fuels equivalent to over 45 billion litres/year of gasoline (12 billion gallons/year).

E
EnerSight Fuels

EnerSight Fuels, Inc. aims to provide standards-compliant biodiesel fuel to fleet operators and end-users in North Alabama and Southern Tennessee.

E
Evolutionary Genomics

Evolutionary Genomics (EG) is a biotechnology company focusing on how relevant gene/target discovery and validation is performed during the post-genomics era. The company's Adapted Traits platform sifts through vast amounts of genomic data to identify only those genes that have a high likelihood of commercial value for downstream validation. EG applies this platform to identify high-value targets for drug-discovery or genes for use in natural crop yield or pest/disease-resistance enhancement.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.